Market shrugs at Durex owner Reckitt’s growth and simplification plan retail Durex condom maker Reckitt Benckiser has pledged to sell off its home care and nutrition brands as part of a simplification drive, instead focusing on health and hygiene.
Reckitt Benckiser: ‘Significant damage’ from tornado will hit baby formula sales Business Baby formula sales at Reckitt Benckiser are set to be hit by “significant damage” to a warehouse which was struck by a tornado, the consumer hygiene company has said.
Reckitt Benckiser: Nutrition arm bruised amid baby formula litigation case Retail Like-for-like sales at its nutrition arm fell by 9.9 per cent to £591m, which more than offset growth of 7.1 per cent at its hygiene arm and one per cent at its health arm.
Shares in Durex maker Reckitt flop as firm misses expectations February 28, 2024 Shares in Durex condom maker Reckitt Benckiser have flopped over nine per cent after the firm missed analyst expectations and revenues showed signs of slowing.
Indivior plans primary US listing in another hit to London’s flagging equity market February 22, 2024 While the firm said it would look to maintain a secondary listing in the UK, the decision to shift its primary listing marks a big change for the company.